Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province

Breast Cancer Research and Treatment

Volumn 120, Issue 1, 2010, Pages 195-202

  Fu, Zhenkun ^a   Li, Dalin ^a   Jiang, Wei ^a   Wang, Lihong ^a   Zhang, Jie ^a   Xu, Fengyan ^a   Pang, Da ^a   Li, Dianjun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

B and T lymphocyte attenuator; Breast cancer; Haplotype; Polymorphism

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LYMPHOCYTE RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CHINA; CHINESE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENES, ERBB-2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 74849138078     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0462-6     Document Type: Article

References (29)

1. L Chen 2004 Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nat Rev Immunol 4 336 347 10.1038/nri1349 1:CAS:528:DC%2BD2cXjsFChsrY%3D 15122199 (Pubitemid 38649276)
2. H Nishimura N Minato T Nakano T Honjo 1998 Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses Int Immunol 10 1563 1572 10.1093/intimm/10.10.1563 1:CAS:528:DyaK1cXms1Kqur0%3D 9796923 (Pubitemid 28451451)
3. N Watanabe M Gavrieli JR Sedy J Yang F Fallarino SK Loftin MA Hurchla N Zimmerman J Sim X Zang 2003 BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 Nat Immunol 4 670 679 10.1038/ni944 1:CAS:528:DC%2BD3sXkvVKqu70%3D 12796776 (Pubitemid 36874444)
4. P Han OD Goularte K Rufner B Wilkinson J Kaye 2004 An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection J Immunol 172 5931 5939 1:CAS:528: DC%2BD2cXjs1Ojt7c%3D 15128774
5. BM Carreno M Collins 2003 BTLA: a new inhibitory receptor with a B7-like ligand Trends Immunol 24 524 527 10.1016/j.it.2003.08.005 1:CAS:528: DC%2BD3sXnvVKktLo%3D 14552835 (Pubitemid 37205202)
6. JR Sedy M Gavrieli KG Potter MA Hurchla RC Lindsley K Hildner S Scheu K Pfeffer CF Ware TL Murphy 2005 B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator Nat Immunol 6 90 98 10.1038/ni1144 1:CAS:528:DC%2BD2cXhtFSjtrzK 15568026 (Pubitemid 40136700)
7. LC Gonzalez KM Loyet J Calemine-Fenaux V Chauhan B Wranik W Ouyang DL Eaton 2005 A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator Proc Natl Acad Sci U S A 102 1116 1121 10.1073/pnas.0409071102 1:CAS:528: DC%2BD2MXhtFCitr0%3D 15647361 (Pubitemid 40170735)
8. N Hamajima 2001 PCR-CTPP: a new genotyping technique in the era of genetic epidemiology Expert Rev Mol Diagn 1 119 123 10.1586/14737159.1.1.119 1:CAS:528:DC%2BD3MXksVCqsb0%3D 11901796
9. BS Shastry 2002 SNP alleles in human disease and evolution J Hum Genet 47 561 566 10.1007/s100380200086 1:CAS:528:DC%2BD38XoslOru78%3D 12436191
10. M Wjst 2004 Target SNP selection in complex disease association studies BMC Bioinformatics 5 92 10.1186/1471-2105-5-92 15248903 (Pubitemid 40195412)
11. M Gavrieli KM Murphy 2006 Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA Biochem Biophys Res Commun 345 1440 1445 10.1016/j.bbrc.2006.05.036 1:CAS:528:DC%2BD28Xltl2gs7k%3D 16725108 (Pubitemid 43817892)
12. JM Chemnitz AR Lanfranco I Braunstein JL Riley 2006 B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs J Immunol 176 6603 6614 1:CAS:528:DC%2BD28XkslWiu7Y%3D 16709818
13. MA Hurchla JR Sedy M Gavrieli CG Drake TL Murphy KM Murphy 2005 B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells J Immunol 174 3377 3385 1:CAS:528:DC%2BD2MXitVehsL4%3D 15749870
14. SC Lin CC Kuo CH Chan 2006 Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis J Biomed Sci 13 853 860 10.1007/s11373-006- 9113-7 1:CAS:528:DC%2BD2sXhs1ylurg%3D 17024343 (Pubitemid 44900657)
15. S Tanrikulu Y Erbil E Ademoglu H Issever U Barbaros F Kutluturk S Ozarmagan S Tezelman 2006 The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal Endocrine 30 377 381 10.1007/s12020-006-0017-0 1:CAS:528:DC%2BD2sXntl2isL4%3D 17526951 (Pubitemid 47010975)
16. N Erfani M Razmkhah AR Talei AM Pezeshki M Doroudchi A Monabati A Ghaderi 2006 Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer Cancer Genet Cytogenet 165 114 120 10.1016/j.cancergencyto.2005.07.020 1:CAS:528:DC%2BD28Xit1aqsL8%3D 16527605 (Pubitemid 43343504)
17. SH Lee YA Lee DH Woo R Song EK Park MH Ryu YH Kim KS Kim SJ Hong MC Yoo, et al. 2006 Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population Arthritis Res Ther 8 R163 10.1186/ar2071 17064404
18. JJ Jonsson MD Foresman N Wilson RS McIvor 1992 Intron requirement for expression of the human purine nucleoside phosphorylase gene Nucleic Acids Res 20 3191 3198 10.1093/nar/20.12.3191 1:CAS:528:DyaK38Xlt1Grsbw%3D 1620616
19. J Majewski J Ott 2002 Distribution and characterization of regulatory elements in the human genome Genome Res 12 1827 1836 10.1101/gr.606402 1:CAS:528:DC%2BD38XpsVOqtbo%3D 12466286 (Pubitemid 35469931)
20. D Baralle M Baralle 2005 Splicing in action: assessing disease causing sequence changes J Med Genet 42 737 748 10.1136/jmg.2004.029538 1:CAS:528:DC%2BD2MXhtFyhu7bL 16199547 (Pubitemid 41475248)
21. V Krauss M Pecyna K Kurz H Sass 2005 Phylogenetic mapping of intron positions: a case study of translation initiation factor eIF2gamma Mol Biol Evol 22 74 84 10.1093/molbev/msh255 1:CAS:528:DC%2BD2cXhtFansrbO 15356279 (Pubitemid 39628544)
22. TH Watts 2005 TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 23 23 68 10.1146/annurev.immunol.23.021704.115839 1:CAS:528:DC%2BD2MXktFOjtb0%3D 15771565 (Pubitemid 40563164)
23. KR Bauer M Brown RD Cress CA Parise V Caggiano 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721 1728 10.1002/cncr.22618 17387718 (Pubitemid 46668532)
24. JS Lee PK Lo MJ Fackler P Argani Z Zhang E Garrett-Mayer S Sukumar 2007 A Comparative Study of Korean with Caucasian Breast Cancer Reveals Frequency of Methylation in Multiple Genes Correlates with Breast Cancer in Young, ER, PR-negative Breast Cancer in Korean Women Cancer Biol Ther 6 1114 1120 10.1158/1535-7163.MCT-07-0002 1:CAS:528:DC%2BD2sXhsVWksrfE 17611401 (Pubitemid 350058157)
25. M Stendahl L Ryden B Nordenskjold PE Jonsson G Landberg K Jirstrom 2006 High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients Clin Cancer Res 12 4614 4618 10.1158/1078-0432.CCR-06-0248 1:CAS:528:DC%2BD28XnvVGks70%3D 16899609 (Pubitemid 44297812)
26. SW Beenken WE Grizzle DR Crowe MG Conner HL Weiss MT Sellers H Krontiras MM Urist KI Bland 2001 Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53 Ann Surg 233 630 638 10.1097/00000658- 200105000-00006 1:STN:280:DC%2BD3MzisFKktg%3D%3D 11323501 (Pubitemid 32378646)
27. C Shimizu T Fukutomi H Tsuda S Akashi-Tanaka T Watanabe T Nanasawa K Sugihara 2000 c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues J Surg Oncol 73 17 20 10.1002/(SICI)1096- 9098(200001)73:1<17::AID-JSO5>3.0.CO;2-2 1:CAS:528:DC%2BD3cXhtFaru7c%3D 10649273 (Pubitemid 30067528)
28. P Rudolph P Alm H Olsson HJ Heidebrecht M Ferno B Baldetorp R Parwaresch 2001 Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer Hum Pathol 32 311 319 10.1053/hupa.2001.22748 1:CAS:528:DC%2BD3MXjtVSgsb4%3D 11274641 (Pubitemid 32246806)
29. AF Logullo AB Lopes S Nonogaki FA Soares MM Netto IN Nishimoto MM Brentani 2007 C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer Oncol Rep 18 121 126 17549356